Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks

View ORCID ProfileNathan J. Edwards, View ORCID ProfileRebecca Widrick, View ORCID ProfileRichard Potember, Mike Gerschefske
doi: https://doi.org/10.1101/2020.07.12.20152157
Nathan J. Edwards
1The MITRE Corporation, Colorado Springs, CO 80910, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nathan J. Edwards
  • For correspondence: nedwards@mitre.org
Rebecca Widrick
1The MITRE Corporation, Colorado Springs, CO 80910, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rebecca Widrick
Richard Potember
2The MITRE Corporation, McLean, VA 22102, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richard Potember
Mike Gerschefske
1The MITRE Corporation, Colorado Springs, CO 80910, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To determine the effectiveness of non-medical grade washable masks or face coverings in controlling airborne dispersion from exhalation (both droplet and aerosol), and to aid in establishing public health strategies on the wearing of masks to reduce COVID-19 transmission.

Design This comparative effectiveness study using an exhalation simulator to conduct 94 experiment runs with combinations of 8 different fabrics, 5 mask designs, and airflows for both talking and coughing.

Setting Non-airtight fume hood and multiple laser scattering particle sensors.

Participants No human participants.

Exposure 10% NaCl nebulized solution delivered by an exhalation simulator through various masks and fabrics with exhalation airflows representative of “coughing” and “talking or singing.”

Main Outcomes and Measures The primary outcome was reduction in aerosol dispersion velocity, quantity of particles, and change in dispersion direction. Measurements used in this study included peak expiratory flow (PEF), aerosol velocity, concentration area under curve (AUC), and two novel metrics of expiratory flow dispersion factor (EDF) and filtration efficiency indicator (FEI).

Results Three-way multivariate analysis of variance establishes that factors of fabric, mask design, and exhalation breath level have a statistically significant effect on changing direction, reducing velocity or concentration (Fabric: P = < .001, Wilks’ Λ = .000; Mask design: P = < .001, Wilks’ Λ = .000; Breath level: P = < .001, Wilks’ Λ = .004). There were also statistically significant interaction effects between combinations of all primary factors.

Conclusions and Relevance The application of facial coverings or masks can significantly reduce the airborne dispersion of aerosolized particles from exhalation. The results show that wearing of non-medical grade washable masks or face coverings can help increase the effectiveness of non-pharmaceutical interventions (NPI) especially where infectious contaminants may exist in shared air spaces. However, the effectiveness varies greatly between the specific fabrics and mask designs used.

STRENGTHS AND LIMITATIONS OF THIS STUDY

  • The strength of this study is that it offers quantitative evidence on the effectiveness of wearing non-medical improvised masks in controlling airborne dispersion of particles from exhalation.

  • Study can aid in establishing public health strategy that encourage the wearing of masks or face coverings for reducing airborne transmission of infectious disease in shared air spaces.

  • A limitation of this study is that is uses an exhalation simulator with the PPE industry standard NaCl test solution for particle generation rather than a clinical study with exhalation of biomaterial particles.

  • The particle sensors used had a limited ability to detect fast moving aerosol clouds from coughing or talking with no-mask applied.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by independent research and development funding provided by the author's organization, The MITRE Corporation. Copyright 2020 The MITRE Corporation. ALL RIGHTS RESERVED. Approved for Public Release; Distribution Unlimited. Public Release Case Number 20-1583

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No human participants, IRB not applicable.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Empirical data may be made available by formal request to author's organization

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 14, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks
Nathan J. Edwards, Rebecca Widrick, Richard Potember, Mike Gerschefske
medRxiv 2020.07.12.20152157; doi: https://doi.org/10.1101/2020.07.12.20152157
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Quantifying Respiratory Airborne Particle Dispersion Control Through Improvised Reusable Masks
Nathan J. Edwards, Rebecca Widrick, Richard Potember, Mike Gerschefske
medRxiv 2020.07.12.20152157; doi: https://doi.org/10.1101/2020.07.12.20152157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10779)
  • Forensic Medicine (8)
  • Gastroenterology (583)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (553)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (864)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)